Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-020302

Chief Financial Officer sold 10,000 shares at $42.54 ($425,400)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2021-03-10 Option exercise +10,000 $6.32 $63,200 31,604 D: show line 1 in the form
Cohen Chad M Chief Financial Officer 2021-03-10 Sale −10,000 $42.54 $425,400 21,604 D: show line 2 in the form
Open-market sales · 10,000 sh · avg $42.54 · $425,400

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Cohen Chad M Chief Financial Officer 2021-03-10 Option exercise · Stock Option (Right to Buy) −10,000 45,000 D: show line 3 in the form
Loading xslF345X03/doc4.xml…